Bulk Manufacturer of Controlled Substances Application: Isosciences, LLC, 79908-79909 [2022-28205]
Download as PDF
<![CDATA[
79908
Federal Register / Vol. 87, No. 248 / Wednesday, December 28, 2022 / Notices
respondent approximately 8 minutes to
complete a response to this IC.
6. An estimate of the total public
burden (in hours) associated with the
collection: The estimated annual public
burden associated with this collection is
6,667, which is equal to 50,000 (total
respondents) * 1 (# of response per
respondent) * .133333 (8 minutes).
If additional information is required
contact: Robert Houser, Department
Clearance Officer, Policy and Planning
Staff, Office of the Chief Information
Officer, Justice Management Division,
United States Department of Justice,
Two Constitution Square, 145 N Street
NE, Mail Stop 3.E–206, Washington, DC
20530.
Dated: December 21, 2022.
Robert Houser,
Department Clearance Officer, Policy and
Planning Staff, Office of the Chief Information
Officer, U.S. Department of Justice.
[FR Doc. 2022–28210 Filed 12–27–22; 8:45 am]
BILLING CODE 4410–FY–P
Drug Enforcement Administration
[Docket No. DEA–1123]
Bulk Manufacturer of Controlled
Substances Application: Isosciences,
LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Isosciences, LLC has applied
to be registered as a bulk manufacturer
of basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before February 27, 2023. Such
persons may also file a written request
for a hearing on the application on or
before February 27, 2023.
SUMMARY:
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on November 11, 2022,
Isosciences, LLC, 340 Mathers Road,
Ambler, Pennsylvania 19002–3420,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
ADDRESSES:
DEPARTMENT OF JUSTICE
ddrumheller on DSK6VXHR33PROD with NOTICES
Controlled substance
Drug code
Cathinone ...................................................................................................................................................................
Methcathinone ............................................................................................................................................................
Lysergic acid diethylamide .........................................................................................................................................
Marihuana ..................................................................................................................................................................
Tetrahydrocannabinols ...............................................................................................................................................
3,4-Methylenedioxyamphetamine ..............................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ..................................................................................................................
3,4-Methylenedioxymethamphetamine ......................................................................................................................
5-Methoxy-N–N-dimethyltryptamine ...........................................................................................................................
Alpha-methyltryptamine ..............................................................................................................................................
Bufotenine ..................................................................................................................................................................
Diethyltryptamine ........................................................................................................................................................
Dimethyltryptamine .....................................................................................................................................................
Psilocybin ...................................................................................................................................................................
Psilocyn ......................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine ........................................................................................................................
Dihydromorphine ........................................................................................................................................................
Heroin .........................................................................................................................................................................
Nicocodeine ................................................................................................................................................................
Nicomorphine .............................................................................................................................................................
Normorphine ...............................................................................................................................................................
Thebacon ...................................................................................................................................................................
Normethadone ............................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylacrylamide) ..........................................................................
Para-Fluorofentanyl ....................................................................................................................................................
3-Methylfentanyl .........................................................................................................................................................
Alpha-methylfentanyl ..................................................................................................................................................
Acetyl-alpha-methylfentanyl .......................................................................................................................................
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4- yl)propionamide .................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylacetamide) ........................................................................
Butyryl Fentanyl .........................................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)isobutyramide) ..................................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N- phenylacetamide ..................................................................................
Beta-hydroxyfentanyl ..................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ...................................................................................................................................
Alpha-methylthiofentanyl ............................................................................................................................................
3-Methylthiofentanyl ...................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylfuran-2-carboxamide) ......................................................
Thiofentanyl ................................................................................................................................................................
Beta-hydroxythiofentanyl ............................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2- carboxamide ....................................................................
Amphetamine .............................................................................................................................................................
VerDate Sep<11>2014
18:26 Dec 27, 2022
Jkt 259001
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
E:\FR\FM\28DEN1.SGM
28DEN1
1235
1237
7315
7360
7370
7400
7404
7405
7431
7432
7433
7434
7435
7437
7438
7439
9145
9200
9309
9312
9313
9315
9635
9811
9812
9813
9814
9815
9816
9821
9822
9824
9825
9830
9831
9832
9833
9834
9835
9836
9843
1100
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
79909
Federal Register / Vol. 87, No. 248 / Wednesday, December 28, 2022 / Notices
Controlled substance
Drug code
Methamphetamine ......................................................................................................................................................
Codeine ......................................................................................................................................................................
Dihydrocodeine ..........................................................................................................................................................
Oxycodone .................................................................................................................................................................
Hydromorphone ..........................................................................................................................................................
Hydrocodone ..............................................................................................................................................................
Isomethadone .............................................................................................................................................................
Methadone .................................................................................................................................................................
Methadone intermediate ............................................................................................................................................
Morphine ....................................................................................................................................................................
Thebaine ....................................................................................................................................................................
Levo-alphacetylmethadol ...........................................................................................................................................
Oxymorphone .............................................................................................................................................................
Thiafentanil .................................................................................................................................................................
Alfentanil .....................................................................................................................................................................
Sufentanil ...................................................................................................................................................................
Carfentanil ..................................................................................................................................................................
Fentanyl ......................................................................................................................................................................
The company plans to manufacture
bulk controlled substances for use in
analytical testing. In reference to drug
codes 7360 (Marihuana) and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetics. No other activities for
these drug codes are authorized for this
registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2022–28205 Filed 12–27–22; 8:45 am]
BILLING CODE P
NATIONAL CREDIT UNION
ADMINISTRATION
Submission for OMB Review;
Comment Request
National Credit Union
Administration (NCUA).
ACTION: Notice.
AGENCY:
The National Credit Union
Administration (NCUA) will submit the
following information collection
requests to the Office of Management
and Budget (OMB) for review and
clearance in accordance with the
Paperwork Reduction Act of 1995, on or
after the date of publication of this
notice.
SUMMARY:
Comments should be received on
or before January 27, 2023 to be assured
of consideration.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
ddrumheller on DSK6VXHR33PROD with NOTICES
DATES:
VerDate Sep<11>2014
18:26 Dec 27, 2022
Jkt 259001
FOR FURTHER INFORMATION CONTACT:
Copies of the submission may be
obtained by contacting Venetia Eldridge
at (703) 518–1564, emailing
PRAComments@ncua.gov, or viewing
the entire information collection request
at www.reginfo.gov.
SUPPLEMENTARY INFORMATION: OMB
Number: 3133–0032.
Type of Review: Extension of a
currently approved collection.
Title: Records Preservation, 12 CFR
part 749.
Abstract: Part 749 of the NCUA
regulations directs each credit union to
have a vital records preservation
program that includes procedures for
maintaining duplicate vital records at a
location far enough from the credit
union’s offices to avoid the
simultaneous loss of both sets of records
in the event of disaster. Part 749 also
requires the program be in writing and
include emergency contact information
for employees, officials, regulatory
offices, and vendors used to support
vital records.
Affected Public: Private Sector: Notfor-profit institutions.
Estimated Total Annual Burden
Hours: 116,472.
OMB Number: 3133–0052.
Type of Review: Extension of a
currently approved collection.
Title: Federal Credit Union Bylaws,
appendix A to part 701.
Abstract: The FCU Act and Bylaws
require new and current FCU to prepare
and maintain documents, such as
organization certificate, charter, notices,
meeting minutes, and election results,
and notify the NCUA Board of certain
changes. FCU’s use the information they
collect and maintain pursuant to their
bylaws in their operations and to
provide services to members. NCUA
uses the information both to regulate the
safety and soundness of FCU and
PO 00000
Frm 00061
Fmt 4703
Sfmt 9990
1105
9050
9120
9143
9150
9193
9226
9250
9254
9300
9333
9648
9652
9729
9737
9740
9743
9801
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
protect the National Credit Union Share
Insurance Fund.
Affected Public: Private Sector: Notfor-profit institutions.
Estimated Total Annual Burden
Hours: 399,298.
OMB Number: 3133–0114.
Type of Review: Extension of a
currently approved collection.
Title: Payments on Shares by Public
Units and Nonmembers, 12 CFR 701.32.
Abstract: Section 107(6) of the Federal
Credit Union Act (Act) and § 701.32 of
the NCUA Rules and Regulations (12
CFR part 701) may receive from public
units and political subdivisions and
nonmember credit unions, payments on
shares. Limitations on nonmember and
public unit deposits in federal credit
unions (FCUs) is 50 percent of the
difference of paid-in and unimpaired
capital and surplus and any public unit
and nonmember shares, as measured at
the time of acceptance of each public
unit or nonmember share. This
collection of information is necessary to
protect the National Credit Union Share
Insurance Fund (NCUSIF).
Affected Public: Private Sector: Notfor-profit institutions.
Estimated Total Annual Burden
Hours: 100.
By Melane Conyers-Ausbrooks,
Secretary of the Board, the National
Credit Union Administration, on
December 21, 2022.
Dated: December 21, 2022.
Venetia Eldridge,
NCUA PRA Clearance Officer.
[FR Doc. 2022–28167 Filed 12–27–22; 8:45 am]
BILLING CODE 7535–01–P
E:\FR\FM\28DEN1.SGM
28DEN1
]]>Agencies
[Federal Register Volume 87, Number 248 (Wednesday, December 28, 2022)]
[Notices]
[Pages 79908-79909]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-28205]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1123]
Bulk Manufacturer of Controlled Substances Application:
Isosciences, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Isosciences, LLC has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
February 27, 2023. Such persons may also file a written request for a
hearing on the application on or before February 27, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on November 11, 2022, Isosciences, LLC, 340 Mathers
Road, Ambler, Pennsylvania 19002-3420, applied to be registered as a
bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Cathinone......................... 1235 I
Methcathinone..................... 1237 I
Lysergic acid diethylamide........ 7315 I
Marihuana......................... 7360 I
Tetrahydrocannabinols............. 7370 I
3,4-Methylenedioxyamphetamine..... 7400 I
3,4-Methylenedioxy-N- 7404 I
ethylamphetamine.
3,4-Methylenedioxymethamphetamine. 7405 I
5-Methoxy-N-N-dimethyltryptamine.. 7431 I
Alpha-methyltryptamine............ 7432 I
Bufotenine........................ 7433 I
Diethyltryptamine................. 7434 I
Dimethyltryptamine................ 7435 I
Psilocybin........................ 7437 I
Psilocyn.......................... 7438 I
5-Methoxy-N,N- 7439 I
diisopropyltryptamine.
Dihydromorphine................... 9145 I
Heroin............................ 9200 I
Nicocodeine....................... 9309 I
Nicomorphine...................... 9312 I
Normorphine....................... 9313 I
Thebacon.......................... 9315 I
Normethadone...................... 9635 I
Acryl fentanyl (N-(1- 9811 I
phenethylpiperidin-4-yl)-N-
phenylacrylamide).
Para-Fluorofentanyl............... 9812 I
3-Methylfentanyl.................. 9813 I
Alpha-methylfentanyl.............. 9814 I
Acetyl-alpha-methylfentanyl....... 9815 I
N-(2-fluorophenyl)-N-(1- 9816 I
phenethylpiperidin-4-
yl)propionamide.
Acetyl Fentanyl (N-(1- 9821 I
phenethylpiperidin-4-yl)-N-
phenylacetamide).
Butyryl Fentanyl.................. 9822 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-
phenethylpiperidin-4-
yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin- 9825 I
4-yl)-N- phenylacetamide.
Beta-hydroxyfentanyl.............. 9830 I
Beta-hydroxy-3-methylfentanyl..... 9831 I
Alpha-methylthiofentanyl.......... 9832 I
3-Methylthiofentanyl.............. 9833 I
Furanyl fentanyl (N-(1- 9834 I
phenethylpiperidin-4-yl)-N-
phenylfuran-2-carboxamide).
Thiofentanyl...................... 9835 I
Beta-hydroxythiofentanyl.......... 9836 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-
carboxamide.
Amphetamine....................... 1100 II
[[Page 79909]]
Methamphetamine................... 1105 II
Codeine........................... 9050 II
Dihydrocodeine.................... 9120 II
Oxycodone......................... 9143 II
Hydromorphone..................... 9150 II
Hydrocodone....................... 9193 II
Isomethadone...................... 9226 II
Methadone......................... 9250 II
Methadone intermediate............ 9254 II
Morphine.......................... 9300 II
Thebaine.......................... 9333 II
Levo-alphacetylmethadol........... 9648 II
Oxymorphone....................... 9652 II
Thiafentanil...................... 9729 II
Alfentanil........................ 9737 II
Sufentanil........................ 9740 II
Carfentanil....................... 9743 II
Fentanyl.......................... 9801 II
------------------------------------------------------------------------
The company plans to manufacture bulk controlled substances for use
in analytical testing. In reference to drug codes 7360 (Marihuana) and
7370 (Tetrahydrocannabinols), the company plans to bulk manufacture
these drugs as synthetics. No other activities for these drug codes are
authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-28205 Filed 12-27-22; 8:45 am]
BILLING CODE P
